About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
UnitedHealth Group Incorporated (UNH) is a Healthcare company in the Healthcare Plans industry with a market capitalisation of $333.8B. The stock trades at 23.90x trailing earnings and yields 2.54%.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Market cap
- $333.8B
- P/E ratio
- 23.90
- Forward P/E
- 16.45
- EPS (TTM)
- $15.56
- Revenue (TTM)
- $450.5B
- Free cash flow
- $24.3B
- Profit margin
- 3.1%
- Dividend yield
- 2.54%
- Beta
- 0.62
- Shares outstanding
- 897.6M
Financial health: Fair5/10
3 strengths, 3 concerns. Weakest points: current ratio, gross margin, net margin.
- Debt to equity: 0.78 (Watch, benchmark < 0.5) — Debt of 0.78x equity is moderate against the 0.5x benchmark. It has deteriorated over the last 4 years.
- Net debt vs cash flow: 3.1y (Watch, benchmark < 4 years) — Net debt of $49.6B is 3.1x annual free cash flow — about 3 years of cash flow to repay.
- Current ratio: 0.79 (Concern, benchmark > 1.5) — Short-term assets cover only 0.79x short-term liabilities — below 1.0, meaning bills due this year exceed the assets on hand to pay them. It has been broadly flat over the last 4 years.
- Return on equity: 14.1% (Watch, benchmark > 15%) — Earns 14.1% on shareholder equity, short of the > 15% mark.
- Gross margin: 19.7% (Concern, benchmark > 40%) — Keeps 19.7% of revenue after the direct cost of sales, well short of the > 40% mark.
- Net margin: 3.1% (Concern, benchmark > 10%) — Turns 3.1% of revenue into profit, well short of the > 10% mark.
- Free cash flow: $16.1B (Strong, benchmark positive) — Generated $16.1B of free cash flow after capital spending. It has deteriorated over the last 4 years.
- Revenue growth: 0.4% (Watch, benchmark > 10%) — Revenue changed 0.4% year on year, short of the > 10% mark.
- Earnings growth: 61.5% (Strong, benchmark > 10%) — Earnings changed 61.5% year on year, comfortably past the > 10% mark.
- PEG ratio: 1.01 (Watch, benchmark < 1) — At 1.01, the price looks fair relative to expected growth — Lynch treated 1.0 as fair value.
- Payout ratio: 57.5% (Strong, benchmark < 60%) — Pays out 57.5% of earnings as dividends, leaving room to keep paying.